BOZZINI, Claudia
 Distribuzione geografica
Continente #
EU - Europa 2.211
NA - Nord America 2.210
AS - Asia 1.182
SA - Sud America 151
AF - Africa 14
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.773
Nazione #
US - Stati Uniti d'America 2.180
RU - Federazione Russa 814
GB - Regno Unito 560
SG - Singapore 451
CN - Cina 412
SE - Svezia 153
FI - Finlandia 152
DE - Germania 140
BR - Brasile 122
FR - Francia 120
HK - Hong Kong 108
IE - Irlanda 105
IT - Italia 64
KR - Corea 57
VN - Vietnam 56
NL - Olanda 39
UA - Ucraina 27
CA - Canada 19
TR - Turchia 19
IN - India 15
BE - Belgio 13
AR - Argentina 11
ID - Indonesia 11
JP - Giappone 11
BD - Bangladesh 10
IL - Israele 7
MX - Messico 7
PL - Polonia 6
AT - Austria 5
ZA - Sudafrica 5
ES - Italia 4
AZ - Azerbaigian 3
CL - Cile 3
EC - Ecuador 3
PK - Pakistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
CO - Colombia 2
EG - Egitto 2
IQ - Iraq 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
SA - Arabia Saudita 2
TG - Togo 2
UY - Uruguay 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EU - Europa 1
HN - Honduras 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MW - Malawi 1
NI - Nicaragua 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
SR - Suriname 1
TN - Tunisia 1
Totale 5.773
Città #
Southend 477
Jacksonville 340
Chandler 287
Moscow 274
Singapore 211
Woodbridge 181
Ashburn 174
Ann Arbor 161
Dallas 144
Houston 112
Hong Kong 108
Dublin 105
New York 68
Helsinki 59
Munich 54
Los Angeles 53
Beijing 41
Lawrence 41
Princeton 41
Lancaster 39
Boardman 37
Nanjing 36
Wilmington 34
Jinan 24
Tianjin 24
Ho Chi Minh City 23
Shenyang 20
Zhengzhou 19
Turku 18
Buffalo 17
Santa Clara 17
São Paulo 17
Falkenstein 16
Milan 16
Changsha 14
Hebei 14
Nanchang 14
Brussels 13
Hanoi 13
Seoul 13
Jiaxing 12
Sindelfingen 12
Denver 11
Redondo Beach 11
Guangzhou 10
Norwalk 10
San Francisco 10
Seattle 10
Tokyo 10
Hangzhou 9
The Dalles 9
Verona 9
Boston 8
Columbus 8
Fuzhou 8
Montreal 7
Rio de Janeiro 7
Taiyuan 7
Toronto 7
Atlanta 6
Lanzhou 6
Mestre 6
Stockholm 6
Warsaw 6
Ankara 5
Haikou 5
Ningbo 5
Cagliari 4
Dongguan 4
Kochi 4
Mexico City 4
Perugia 4
Poplar 4
San Mateo 4
Vienna 4
Washington 4
Amsterdam 3
Baku 3
Brasília 3
Brooklyn 3
Campinas 3
Chicago 3
Clearwater 3
Fairfield 3
Fortaleza 3
Jakarta 3
Kent 3
London 3
Orem 3
Phoenix 3
Porto Alegre 3
Rome 3
Secaucus 3
Shijiazhuang 3
St Louis 3
Topeka 3
Augusta 2
Baghdad 2
Bangalore 2
Belo Horizonte 2
Totale 3.693
Nome #
Novel serum paraoxonase activity assays are associated with coronary artery disease 187
Biochemical and genetic markers of iron status and the risk of coronary disease 172
Clinical and pathological findings in hemochromatosis type 3 due to a novel mutation in transferin receptor 2 gene 164
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 164
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis. 163
Hyperhomocysteinemia and mortality after coronary artery by-pass grafing. 160
Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting 159
Low circulating vitamin B6 markers of inflammation, and risk of coronary artery disease. 156
Interaction between folate and MTHFR1298 A/C polymorphism on Genomic DNA Methylation 154
Clinical heterogeneity of acquired hemophilia A: a description of 4 cases. 153
Interaction between metabolic syndrome and PON 1 polymorphism as a determinant of the risk of coronary artery disease 152
Factor VIII:c Levels in Subjects with the Factor V R2 Polymorphism. 148
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project. 147
A new mutation in transferrin receptor 2 gene in hemochromatosis type 3 145
Determinants of serum ferritin in the metabolic syndrome. 144
Determinants of serum ferritin and prevalence of iron overload in the Metabolic (Insulin Resistance). 143
Low vitamin B6, markers of inflammation, and risk of coronary artery disease. 143
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. 142
Interaction between PON 2 polymorphism Ser-Cys and smoking as a determinant of myocardial infarction risk 142
High levels of homocysteine are associated with small number of traditional cardiovascular risk factors in patients with similar degree of coronary atherosclerosis. 142
Prevalence of body iron excess in the metabolic syndrome. 141
Clinical,biochemical and molecular findings in a series of families with hereditary hyperferritinemia cataract syndrome 141
BIOCHEMICAL AND GENETIC MARKERS OF IRON STATUS AND RISK OF CORONARY ARTERY DISEASE: AN ANGIOGRAPHIC-BASED STUDY. 136
Two new highly polymorphic markers in the 3’UTR region of the PLA2G7 gene 136
CLINICAL AND HISTOPATHOLOGICAL FINDINGS IN A FAMILY WITH HEMOCROMATOSIS TYPE 3, CARRING A NEW MUTATION IN TRANSFERRIN RECEPTOR 2 GENE 135
A new mutation in the trnsferrin receptor 2 gene in hemochromatosis type 3 134
Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis. 131
Met-Leu and Gln-Arg PON 1 polymorphisms and mortality after coronary artery by-pass grafing surgery. 126
Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis. 120
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 116
Blunted hepcidin response to oral iron challenge in BFE-related hemochromatosis 115
Prevalence of hereditary hyperferritinemia-catarat siyndrome in blood donors and in patients with cataract 112
Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery disease 109
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 107
Influence of the polymorphism in the factor VII gene promoter on Factor VII circulating levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 106
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 106
Molecular pathology of hereditary hemochromatosis 105
Increase arachidonic/linoleic acid ratio and a polygenic model of desaturases polymorphism are associated with increase risk of coronary artery disease 98
Polymorphism in the factor VII gene promoter (-323°1°2 and -402 GA) and the risk of myocardial infarction in patients with advance coronary atherosclerosis 87
Measurament of urinary hepcidin levels by self-tof-ms in HFE-hemochromatosis 85
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches 78
Prevalence of hereditary hyperferritinemia-cataract syndrome in blood donors and in patients with cataract. 78
A case series of patients with β-thalassemia trait and iron overload: from multifactorial hepcidin suppression to treatment with mini-phlebotomies 75
Serum Erythroferrone in a Large General Population: Towards a Better Understanding of Connections Between Erythropoiesis and Iron Homeostasis 72
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 61
Totale 5.790
Categoria #
all - tutte 18.176
article - articoli 8.643
book - libri 0
conference - conferenze 9.206
curatela - curatele 0
other - altro 327
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.352


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021204 0 0 0 0 35 40 5 44 40 2 37 1
2021/2022296 26 70 3 33 18 9 4 18 6 13 28 68
2022/2023803 47 84 74 143 97 179 5 36 95 10 15 18
2023/2024411 8 29 27 44 42 77 9 34 5 18 56 62
2024/2025922 49 74 71 156 32 40 28 17 80 45 93 237
2025/20261.665 199 152 148 484 682 0 0 0 0 0 0 0
Totale 5.790